Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T17:10:10.140Z Has data issue: false hasContentIssue false

Desflurane inhibits platelet function in vitro similar to halothane

Published online by Cambridge University Press:  11 July 2005

T. Berlet
Affiliation:
University Hospital, Department of Anaesthesiology, Cologne, Germany
A. Krah
Affiliation:
University Hospital, Department of Transfusion Medicine, Cologne, Germany
U. Börner
Affiliation:
University Hospital, Department of Anaesthesiology, Cologne, Germany
B. S. Gathof
Affiliation:
University Hospital, Department of Transfusion Medicine, Cologne, Germany
Get access

Abstract

Summary

Background and objective: The effects of the volatile anaesthetic desflurane on platelet activation in vitro were studied and compared to those of halothane.

Methods: Platelet-rich plasma was exposed to 2 MAC of desflurane or halothane, or air only and stimulated by platelet agonists ADP (2.5, 5 and 10 μmol L−1) and collagen (10 μg mL−1). Platelet response was measured by Born aggregometry (maximum aggregation response, area under the curve) and flow cytometry (mean channel fluorescence, percentage of CD62P-positive cells, index of platelet activation for positive platelets).

Results: Aggregation response was significantly reduced in platelets exposed to desflurane or halothane; the inhibitory effect was more pronounced when the areas under the curve were analysed: values ranged from 37.5% to 73.3% of control samples for ADP stimulation and 77.1% to 79.8% for collagen stimulation. CD62P expression before and after stimulation with receptor agonists was not statistically different in platelets exposed to desflurane, halothane or air.

Conclusions: By impairing platelet aggregation while not affecting α-degranulation desflurane has a differential effect on various aspects of platelet activation similar to halothane. Our results are compatible with the hypothesis of an impairment of platelet thromboxane receptor signalling by halothane. We suggest a similar mechanism for desflurane.

Type
Original Article
Copyright
2003 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ueda I. The effects of volatile general anesthetics on adenosine diphosphate-induced platelet aggregation. Anesthesiology 1971; 34: 405408.Google Scholar
Dalsgaard-Nielsen J, Risbo A, Simmelkjaer P, Gormsen J. Impaired platelet aggregation and increased bleeding time during general anaesthesia with halothane. Br J Anaesth 1981; 53: 10391042.Google Scholar
Fyman PN, Triner L, Schranz H, et al. Effect of volatile anaesthetics and nitrous oxide-fentanyl anaesthesia on bleeding time. Br J Anaesth 1984; 56: 11971200.Google Scholar
De Rossi LW, Horn NA, Baumert JH, Gutensohn K, Hutschenreuter G, Rossaint R. Xenon does not affect human platelet function in vitro. Anesth Analg 2001; 93: 635640.Google Scholar
Cambria RP, Megerman J, L'Italien G, Warnock D, Strauss HW, Abbott WM. The effect of halothane anesthesia on platelet aggregation in vivo: decreased deposition on polytetrafluoroehtylene arterial grafts in dogs. Surgery 1983; 93: 752757.Google Scholar
Schlack W, Preckel B, Stunneck D, Thämer V. Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998; 81: 913919.Google Scholar
Longnecker DE, Miller FL. Pharmacology of inhalational anesthetics. In: Rogers MC, et al., eds. Principles and Practice of Anesthesiology.St. Louis, USA: Mosby, 1993: 10531086.
Baden JM, Rice SA. Metabolism and toxicity of inhaled anesthetics. In: Miller RD, ed. Anaesthesia, 5th edn. New York, USA: Churchill Livingstone, 2000: 156162.
Leytin V, Mody M, Semple JW, Garbey B, Freedman J. Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations. Biochem Biophys Res Commun 2000; 269: 8590.Google Scholar
Snyder EL, Hezzey A, Katz AJ, Bock J. Occurrence of the release reaction during preparation and storage of platelet concentrates. Vox Sang 1981; 41: 172177.Google Scholar
Holmsen H. Platelet secretion and energy metabolism. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis, 3rd edn. Philadelphia, USA: Lippincott, 1994: 524540.
Reuter HD. Basic Elements and Practice of Platelet Function Diagnostics, 2nd edn. Köln, Germany: Science Data Supply, 1999.
Colman RW, Cook JJ, Niewiarowski S. Mechanisms of platelet aggregation. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis, 3rd edn. Philadelphia, USA: Lippincott, 1994: 508523.
Charo LF, Dieffer N, Phillips DR. Platelet membrane glycoproteins. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis, 3rd edn. Philadelphia, USA: Lippincott, 1994: 489503.
Merten M, Thiagarajan P. P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000; 102: 19311936.Google Scholar
Matzdorff AC, Kemkes-Matthes B, Voss R, Pralle H. Comparison of β-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation. Haemostasis 1996; 26: 98106.Google Scholar
Walter F, Vulliemoz Y, Verosky M, Triner L. Effects of halothane on the cyclic 3′,5′ adenosine monophosphate enzyme system in human platelets. Anesth Analg 1980; 59: 856861.Google Scholar
Dalsgaard-Nielsen J, Gormsen J. Effects of halothane on platelet function. Thromb Haemost 1980; 44: 143145.Google Scholar
Hirakata H, Ushikubi F, Narumiya S, Hatano Y, Nakamura K, Mori K. The effect of inhaled anesthetics on the platelet aggregation and the ligand-binding affinity of the platelet thromboxane A2-receptor. Anesth Analg 1995; 81: 114118.Google Scholar
Hirakata H, Ushikubi F, Toda H, et al. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. Anesthesiology 1996; 85: 14471453.Google Scholar
Hirakata H, Nakamura K, Sai S, et al. Platelet aggregation is impaired during anaesthesia with sevoflurane but not with isoflurane. Can J Anesth 1997; 44: 11571161.Google Scholar
Kohro S, Yamakage M. Direct inhibitory mechanisms of halothane on human platelet aggregation. Anesthesiology 1996; 85: 96106.Google Scholar
Corbin F, Blaise G, Sauvé R. Differential effect of halothane and forskolin on platelet cytosolic Ca2+ mobilization and aggregation. Anesthesiology 1998; 89: 401410.Google Scholar
Hönemann CW, Nietgen GW, Podranski T, Chan CK, Durieux ME. Influence of volatile anesthetics on thromboxane A2 signaling. Anesthesiology 1998; 88: 440451.Google Scholar
Nygård E, Naesh O, Hindberg I, Valentin N. Effect of nitrous oxide and volatile anaesthetics on platelet function in man. Acta Anaesthesiol Scand 1994; 38: 4042.Google Scholar
Fröhlich D, Rothe G, Schmitz G, Hansen E. Volatile anaesthetics induce changes in the expression of P-selectin and glycoprotein Ib on the surface of platelets in vitro. Eur J Anaesthesiol 1998; 15: 641648.Google Scholar
Eger EI. Uptake and distribution. In: Miller RD, ed. Anesthesia, 5th edn. New York, USA: Churchill Livingstone, 2000: 7494.